176 related articles for article (PubMed ID: 1724633)
1. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
3. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
[TBL] [Abstract][Full Text] [Related]
4. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
[TBL] [Abstract][Full Text] [Related]
5. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
7. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
9. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
10. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
[TBL] [Abstract][Full Text] [Related]
11. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
13. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
14. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
Pigott J; Nichols R; Maddox WA; Balch CM
Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
[TBL] [Abstract][Full Text] [Related]
15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
16. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
17. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
18. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.
Fréneaux P; Nos C; Vincent-Salomon A; Genin P; Sigal-Zafrani B; Al Ghuzlan A; Birolini MJ; Clough K; Sastre-Garau X
Mod Pathol; 2002 Jun; 15(6):641-6. PubMed ID: 12065778
[TBL] [Abstract][Full Text] [Related]
19. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
20. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
